日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study

iLLUMINATE 研究分析显示，伊布替尼预处理可降低慢性淋巴细胞白血病 (CLL) 患者的细胞因子分泌，并限制奥妥珠单抗输注相关反应的风险。

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-021-04536-6
Greil, Richard; Tedeschi, Alessandra; Moreno, Carol; Anz, Bertrand; Larratt, Loree; Simkovic, Martin; Gill, Devinder; Gribben, John G; Flinn, Ian W; Wang, Zhengyuan; Cheung, Leo W K; Nguyen, Aaron N; Zhou, Cathy; Styles, Lori; Demirkan, Fatih
白血病
细胞生物学
免疫/内分泌
发表日期：2021
文献求助 收藏

Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment.

抑制 p38α MAPK 可破坏骨髓增生异常综合征骨髓微环境中促炎因子产生的病理循环

期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.1080/10428190802322919
Navas Tony, Zhou Li, Estes Myka, Haghnazari Edwin, Nguyen Aaron N, Mo Yongkai, Pahanish Perry, Mohindru Mani, Cao Tim, Higgins Linda S, Platanias Leonidas C, List Alan, Verma Amit, Bhagat T, Gajavelli S, Kambhampati S
免疫/内分泌
发表日期：2008
文献求助 收藏

Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors.

抑制过度激活的p38 MAPK可以恢复骨髓增生异常综合征祖细胞的造血功能

期刊:Blood
影响因子:23.1
doi:10.1182/blood-2006-05-023093
Navas Tony A, Mohindru Mani, Estes Myka, Ma Jing Ying, Sokol Lubomir, Pahanish Perry, Parmar Simrit, Haghnazari Edwin, Zhou Li, Collins Robert, Kerr Irene, Nguyen Aaron N, Xu Yin, Platanias Leonidas C, List Alan A, Higgins Linda S, Verma Amit
细胞生物学
p38 MAPK
发表日期：2006
文献求助 收藏